Hello, the spectral methyl catalytic treatment device you are talking about was launched by the German Wanman Medical Company in October 2016. The main function of this treatment device is to treat specific neural tissues. Precise regulation of cell methylation process is mainly used as an auxiliary treatment for insomnia, depression, schizophrenia and other mental diseases.
So what is methyl catalysis?
What is methyl catalysis: Methyl catalysis refers to the process of methylation, which consists of one carbon atom and three hydrogen atoms. Methyl groups are added to or removed from other molecules. It is a biochemical process by which the body manufactures needed substances or decomposes unnecessary substances. In biological systems, methylation is catalyzed by enzymes. This methylation process involves heavy metal modification, regulation of gene expression, regulation of protein function, and ribonucleic acid (RNA) processing.
Then methylation plays a key role in the normal replication of DNA and the closure of genes in cells. Methyl groups can be added to or removed from DNA. When the degree of methylation is insufficient, our DNA cannot be repaired well, and cells cannot make full use of various substances in the body's internal environment to produce various substances necessary for their own metabolism, thus putting us at a higher risk of various diseases. at risk of disease. Defective methylation leads to cellular metabolic dysfunction, the accumulation of external toxins such as pesticides, and an excess of hormones such as estrogen in the body, which has been linked to an increase in several cancers.
The body can use the methylation process to remove some heavy metal toxins, such as mercury, lead, antimony, and arsenic. If your methylation is defective, these heavy metal toxins can accumulate and interfere with many functions in the body. The liver can use the methylation process to eliminate external toxins, as well as some of its own chemical waste products, such as hormonal by-products.
In addition, the methylation reaction is also crucial to the normal function of the brain. For example, the brain uses methylation to form acetylcholine, the neurotransmitter required for memory. The decline in acetylcholine levels is associated with memory loss and premature aging. Dementia is related.
This device was developed by the Medical Research Institute of Heidelberg University in 2014, and was the first to be used in clinical practice.
Then, in 2015, three countries were the first to introduce this equipment, namely the United States, the Netherlands, and Japan, and they were quickly used clinically.
In October 2017, this thing was also introduced in China. It was supported by the National Health and Family Planning Commission (formerly the Ministry of Health) and the Chinese Psychiatric Rehabilitation Association and other large and small institutions. Next, this equipment was introduced to China, and then it was introduced to Nanchang Erqi Hospital in East China. It is said to be the first hospital.